Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
VH3810109 for Human Immunodeficiency Virus Infection
Recruiting1 awardPhase 1
Austin, Texas
This trial will study the safety and tolerability of VH3810109 given by injection, either under the skin or into a vein. Participants will be given a single dose of the drug and will be monitored for side effects for 24 weeks.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.